September 9, 2026
We say this a lot lately, and we'll say it again: none of today's headlines are about humanoid or bipedal robots. Two are about biomimetic swimmers -- a frog-muscle-actuated manta ray and a scalable robotic fish -- and one is about the state of US robotics policy. That's worth noting on its own. The humanoid robotics narrative that dominated headlines earlier this year has gone quiet in the general robotics press this week, and readers evaluating automation investments should resist the urge to assume the field is progressing at the breakneck pace the marketing suggests. Real hardware news, on days like today, is happening in aquatic biomimicry labs and policy think pieces, not on factory floors with two-legged robots.
Robohub's spotlight on the United States, authored by Ellen H. Rumley and Allison Okamura, makes a point that's easy to skip past but shouldn't be: American robotics researchers and industry are pushing for a cohesive national strategy that keeps basic research funded while also improving domestic manufacturing and adoption of robots. That's not a minor bureaucratic footnote. Countries with unified roadmaps -- and several already have them, which is presumably why this is being framed as a US gap -- tend to align funding, standards, and workforce training in ways that compound over a decade. The US, by contrast, has historically let its robotics innovation happen in a scattered mix of DARPA-funded labs, university spinouts, and venture capital bets, with adoption lagging well behind invention.
For a business reader, the takeaway isn't abstract. If the US doesn't coordinate policy around production and adoption, the practical effect is slower, choppier availability of affordable industrial and eventually humanoid robots domestically, even if the underlying research stays world-class. Companies planning multi-year automation roadmaps should treat this as a reason to diversify their assumptions about where hardware and supply chains will mature fastest -- it may not be the US, even if the science originates there. We've made similar points before about how the humanoid robotics story keeps not showing up in the actual hardware pipeline; a fragmented national strategy is one structural reason why.
The two New Atlas stories -- a manta ray robot actuated by literal frog leg muscle from researchers at the Chinese Academy of Sciences, and a scalable robotic fish called SCaFi from NYU's Tandon School of Engineering -- are genuinely clever biomimicry work. Muscle-based actuation and fish-like locomotion that scales to different sizes both solve real engineering problems around efficiency and adaptability in underwater robotics. But it's important to be honest about where these sit on the commercialization timeline: this is early-stage biomimicry research, years away from any deployable product, let alone anything touching humanoid form factors or general business automation. We'd rather tell readers plainly that today's most interesting robotics science isn't yet actionable for a company deciding whether to invest in warehouse automation or customer-facing robotics, rather than stretch it into relevance it doesn't have.
Where this research does matter, longer term, is as a reminder that the components inside future robots -- actuators, artificial muscle, adaptive locomotion -- are still being reinvented from scratch by biology-inspired labs around the world. That's a slower, quieter pipeline than the humanoid hype cycle, but it's arguably the one that determines whether the humanoids promised for 2027 or 2028 actually work as advertised.
If you're a business leader tracking robotics for planning purposes, the signal from today isn't a product launch -- it's a policy gap and some interesting lab science. Neither should change your near-term automation plans, and companies still deciding how to prioritize AI and software workflow automation before hardware robotics matures might get more immediate value from tools like Workflow Automation than from waiting on humanoid hardware. We'll keep flagging when genuine humanoid news breaks, but we're not going to manufacture urgency where the headlines don't support it.
Do you think a coordinated national robotics strategy would actually speed up humanoid deployment in the US, or is that giving policy too much credit for what's fundamentally an engineering problem?
Sources